Periodic Reporting for period 1 - breast cancer dormancy (Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy)

"Endocrine therapy has clearly improved outcomes for oestrogen receptor alpha-positive (ER+) breast cancer patients. However, the cumulative incidence of recurrence and death continues at a steady rate. The majority of ER+ breast tumours treated with neoadjuvant letrozole...